World Health Organization suspends chloroquine trials

. May 25, 2020
World Health Organization suspends chloroquine trials Photo: Ed2806/Shutterstock

The World Health Organization informed that the international Solidarity trial — which gathered 100 countries to test new drugs against Covid-19 — has suspended research with antimalarial drugs hydroxychloroquine and chloroquine. In Brazil, the Oswaldo Cruz Foundation is responsible for carrying out such tests. 

The decision was made after a study involving 96,000 patients published by medical journal Lancet showed chloroquine wasn’t effective and could cause heart issues, such as arrhythmia, leading to a higher mortality rate. 

Even before suspending the trials, WHO authorities were careful towards chloroquine and said the medicine shouldn’t be used outside clinical trials. In Brazil, however, the Health Ministry has published a recommendation for the public health system to prescribe the medicine in Covid-19 patients from the very early stages of the disease onward, going against advice from medical associations

Support this coverage →Support this coverage →
Natália Scalzaretto

Natália Scalzaretto has worked for companies such as Santander Brasil and Reuters, where she covered news ranging from commodities to technology. Before joining The Brazilian Report, she worked as an editor for Trading News, the information division from the TradersClub investor community.

Our content is protected by copyright. Want to republish The Brazilian Report? Email us at